Triptans use and overuse: A pharmacoepidemiology study from the French health insurance system database covering 4.1 million people

Conclusions
This work suggests that triptan overuse may be due to insufficient prescriber awareness of appropriate prescribing. The off-label prescription of triptans among the elderly necessitates investigating their cardiovascular risk profile in this sub-group.

Source: Cephalalgia - November 4, 2015 Category: Neurology Authors: Braunstein, D., Donnet, A., Pradel, V., Sciortino, V., Allaria-Lapierre, V., Lanteri-Minet, M., Micallef, J. Tags: Original Articles Source Type: research